• Je něco špatně v tomto záznamu ?

Gestational age is more important for short-term neonatal outcome than microbial invasion of the amniotic cavity or intra-amniotic inflammation in preterm prelabor rupture of membranes

A. Rodríguez-Trujillo, T. Cobo, I. Vives, J. Bosch, M. Kacerovsky, DE. Posadas, MA. Ángeles, E. Gratacós, B. Jacobsson, M. Palacio,

. 2016 ; 95 (8) : 926-33. [pub] 20160426

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013963

INTRODUCTION: The aim of this study was to evaluate, in women with preterm prelabor rupture of membranes (PPROM), the impact on short-term neonatal outcome of microbial invasion of the amniotic cavity (MIAC), intra-amniotic inflammation (IAI), and the microorganisms isolated in women with MIAC, when gestational age is taken into account. MATERIAL AND METHODS: Prospective cohort study. We included women with PPROM (22.0-34.0 weeks of gestation) with available information about MIAC, IAI and short-term neonatal outcome. MIAC was defined as positive aerobic/anaerobic/genital Mycoplasma culture in amniotic fluid. Definition of IAI was based on interleukin-6 levels in amniotic fluid. Main outcome measures were Apgar score <7 at 5 min, umbilical artery pH ≤7.0, days in the neonatal intensive care unit, and composite neonatal morbidity, including any of the following: intraventricular hemorrhage grade III-IV, respiratory distress syndrome, early-onset neonatal sepsis, periventricular leukomalacia, necrotizing enterocolitis, and fetal or neonatal death. Labor was induced after 32.0 weeks if lung maturity was confirmed; and otherwise after 34.0 weeks. RESULTS: MIAC and IAI were found in 38% (72/190) and 67% (111/165), respectively. After adjustment for gestational age at delivery, no differences in short-term neonatal outcome were found between women with either MIAC or IAI, compared with the non-infection/non-inflammation ("No-MIAC/No-IAI") group. Furthermore, short-term neonatal outcome did not differ between the MIAC caused by Ureaplasma spp. group, the MIAC caused by other microorganisms group and the "No-MIAC/No-IAI" group. CONCLUSIONS: Gestational age at delivery seems to be more important for short-term neonatal outcome than MIAC or IAI in PPROM.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013963
003      
CZ-PrNML
005      
20170425095627.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/aogs.12905 $2 doi
035    __
$a (PubMed)27061307
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rodríguez-Trujillo, Adriano $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain.
245    10
$a Gestational age is more important for short-term neonatal outcome than microbial invasion of the amniotic cavity or intra-amniotic inflammation in preterm prelabor rupture of membranes / $c A. Rodríguez-Trujillo, T. Cobo, I. Vives, J. Bosch, M. Kacerovsky, DE. Posadas, MA. Ángeles, E. Gratacós, B. Jacobsson, M. Palacio,
520    9_
$a INTRODUCTION: The aim of this study was to evaluate, in women with preterm prelabor rupture of membranes (PPROM), the impact on short-term neonatal outcome of microbial invasion of the amniotic cavity (MIAC), intra-amniotic inflammation (IAI), and the microorganisms isolated in women with MIAC, when gestational age is taken into account. MATERIAL AND METHODS: Prospective cohort study. We included women with PPROM (22.0-34.0 weeks of gestation) with available information about MIAC, IAI and short-term neonatal outcome. MIAC was defined as positive aerobic/anaerobic/genital Mycoplasma culture in amniotic fluid. Definition of IAI was based on interleukin-6 levels in amniotic fluid. Main outcome measures were Apgar score <7 at 5 min, umbilical artery pH ≤7.0, days in the neonatal intensive care unit, and composite neonatal morbidity, including any of the following: intraventricular hemorrhage grade III-IV, respiratory distress syndrome, early-onset neonatal sepsis, periventricular leukomalacia, necrotizing enterocolitis, and fetal or neonatal death. Labor was induced after 32.0 weeks if lung maturity was confirmed; and otherwise after 34.0 weeks. RESULTS: MIAC and IAI were found in 38% (72/190) and 67% (111/165), respectively. After adjustment for gestational age at delivery, no differences in short-term neonatal outcome were found between women with either MIAC or IAI, compared with the non-infection/non-inflammation ("No-MIAC/No-IAI") group. Furthermore, short-term neonatal outcome did not differ between the MIAC caused by Ureaplasma spp. group, the MIAC caused by other microorganisms group and the "No-MIAC/No-IAI" group. CONCLUSIONS: Gestational age at delivery seems to be more important for short-term neonatal outcome than MIAC or IAI in PPROM.
650    _2
$a plodová voda $x mikrobiologie $7 D000653
650    _2
$a Apgar skóre $7 D001034
650    _2
$a aerobní bakterie $x izolace a purifikace $7 D001420
650    _2
$a anaerobní bakterie $x izolace a purifikace $7 D001421
650    _2
$a chorioamnionitida $x diagnóza $x etiologie $x mikrobiologie $7 D002821
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a předčasný odtok plodové vody $x mikrobiologie $7 D005322
650    12
$a gestační stáří $7 D005865
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a novorozenec nedonošený $7 D007234
650    _2
$a nemoci nedonošenců $x etiologie $x terapie $7 D007235
650    _2
$a intenzivní péče o novorozence $x statistika a číselné údaje $7 D015931
650    _2
$a logistické modely $7 D016015
650    _2
$a Mycoplasma $x izolace a purifikace $7 D009174
650    _2
$a těhotenství $7 D011247
650    _2
$a výsledek těhotenství $7 D011256
650    _2
$a prospektivní studie $7 D011446
650    _2
$a Ureaplasma $x izolace a purifikace $7 D014509
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cobo, Teresa $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain. Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
700    1_
$a Vives, Irene $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain.
700    1_
$a Bosch, Jordi $u Microbiology, Biomedical Diagnostic Center, Hospital Clínic and ISGlobal Barcelona Institute for Global Health, University of Barcelona, Barcelona, Spain.
700    1_
$a Kacerovsky, Marian $u Department of Obstetrics and Gynecology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Posadas, David E $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain.
700    1_
$a Ángeles, Martina A $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain.
700    1_
$a Gratacós, Eduard $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain. Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
700    1_
$a Jacobsson, Bo $u Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden. Department of Genetics and Bioinformatics, Area of Health Data and Digitalization, Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Palacio, Montse $u BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain. Center for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain.
773    0_
$w MED00009026 $t Acta obstetricia et gynecologica Scandinavica $x 1600-0412 $g Roč. 95, č. 8 (2016), s. 926-33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27061307 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170425095944 $b ABA008
999    __
$a ok $b bmc $g 1200428 $s 974741
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 95 $c 8 $d 926-33 $e 20160426 $i 1600-0412 $m Acta obstetricia et gynecologica Scandinavica $n Acta Obstet Gynecol Scand $x MED00009026
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...